These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 30782181

  • 1. Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Lee JD, Liu N, Levin SC, Ottosson L, Andersson U, Harris HE, Woodruff TM.
    J Neuroinflammation; 2019 Feb 19; 16(1):45. PubMed ID: 30782181
    [Abstract] [Full Text] [Related]

  • 2. Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.
    Lee JD, McDonald TS, Fung JNT, Woodruff TM.
    Mol Neurobiol; 2020 Oct 19; 57(10):4143-4155. PubMed ID: 32676989
    [Abstract] [Full Text] [Related]

  • 3. Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Lee JY, Lee JD, Phipps S, Noakes PG, Woodruff TM.
    J Neuroinflammation; 2015 May 13; 12():90. PubMed ID: 25962427
    [Abstract] [Full Text] [Related]

  • 4. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A, Barhum Y, Angel A, Perets N, Steiner I, Offen D, Lev N.
    Int J Mol Sci; 2017 Aug 01; 18(8):. PubMed ID: 28763002
    [Abstract] [Full Text] [Related]

  • 5. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1G93A murine model of amyotrophic lateral sclerosis in a sex-dependent manner.
    MacLean M, Juranek J, Cuddapah S, López-Díez R, Ruiz HH, Hu J, Frye L, Li H, Gugger PF, Schmidt AM.
    J Neuroinflammation; 2021 Jun 15; 18(1):139. PubMed ID: 34130712
    [Abstract] [Full Text] [Related]

  • 6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G.
    Neurobiol Dis; 2014 Apr 15; 64():48-59. PubMed ID: 24361555
    [Abstract] [Full Text] [Related]

  • 7. Novel insights into RAGE signaling pathways during the progression of amyotrophic lateral sclerosis in RAGE-deficient SOD1 G93A mice.
    Nowicka N, Zglejc-Waszak K, Juranek J, Korytko A, Wąsowicz K, Chmielewska-Krzesińska M, Wojtkiewicz J.
    PLoS One; 2024 Apr 15; 19(3):e0299567. PubMed ID: 38457412
    [Abstract] [Full Text] [Related]

  • 8. The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice.
    Nowicka N, Szymańska K, Juranek J, Zglejc-Waszak K, Korytko A, Załęcki M, Chmielewska-Krzesińska M, Wąsowicz K, Wojtkiewicz J.
    Int J Mol Sci; 2022 Feb 16; 23(4):. PubMed ID: 35216298
    [Abstract] [Full Text] [Related]

  • 9. Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical results.
    Paudel YN, Angelopoulou E, Piperi C, Othman I, Shaikh MF.
    Pharmacol Res; 2020 Jun 16; 156():104792. PubMed ID: 32278047
    [Abstract] [Full Text] [Related]

  • 10. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Bonifacino T, Cattaneo L, Gallia E, Puliti A, Melone M, Provenzano F, Bossi S, Musante I, Usai C, Conti F, Bonanno G, Milanese M.
    Neuropharmacology; 2017 Sep 01; 123():433-445. PubMed ID: 28645622
    [Abstract] [Full Text] [Related]

  • 11. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
    Nardo G, Iennaco R, Fusi N, Heath PR, Marino M, Trolese MC, Ferraiuolo L, Lawrence N, Shaw PJ, Bendotti C.
    Brain; 2013 Nov 01; 136(Pt 11):3305-32. PubMed ID: 24065725
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX, Mok SS, Laughton KM, McLean CA, Volitakis I, Cherny RA, Cheung NS, White AR, Masters CL.
    Aging Cell; 2006 Apr 01; 5(2):153-65. PubMed ID: 16626394
    [Abstract] [Full Text] [Related]

  • 13. Effects of RAGE inhibition on the progression of the disease in hSOD1G93A ALS mice.
    Liu L, Killoy KM, Vargas MR, Yamamoto Y, Pehar M.
    Pharmacol Res Perspect; 2020 Aug 01; 8(4):e00636. PubMed ID: 32776498
    [Abstract] [Full Text] [Related]

  • 14. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y, Guo Y, Wang X, Yu X, Duan W, Hong K, Wang J, Han H, Li C.
    Neuroscience; 2015 Jul 09; 298():12-25. PubMed ID: 25841320
    [Abstract] [Full Text] [Related]

  • 15. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D, Romberg CF, Dobrowolny G, Martini M, Voss AA, Musarò A, Bannister RA.
    Skelet Muscle; 2016 Jul 09; 6():24. PubMed ID: 27340545
    [Abstract] [Full Text] [Related]

  • 16. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM, Smit-Oistad IM, Macrander C, Krakora D, Meyer MG, Suzuki M.
    Exp Neurol; 2016 Mar 09; 277():275-282. PubMed ID: 26775178
    [Abstract] [Full Text] [Related]

  • 17. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S, Amadio S, Montilli C, Volonté C, D'Ambrosi N.
    Hum Mol Genet; 2013 Oct 15; 22(20):4102-16. PubMed ID: 23736299
    [Abstract] [Full Text] [Related]

  • 18. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Bryson JB, Hobbs C, Parsons MJ, Bosch KD, Pandraud A, Walsh FS, Doherty P, Greensmith L.
    Hum Mol Genet; 2012 Sep 01; 21(17):3871-82. PubMed ID: 22678056
    [Abstract] [Full Text] [Related]

  • 19. Altered development in GABA co-release shapes glycinergic synaptic currents in cultured spinal slices of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Medelin M, Rancic V, Cellot G, Laishram J, Veeraraghavan P, Rossi C, Muzio L, Sivilotti L, Ballerini L.
    J Physiol; 2016 Jul 01; 594(13):3827-40. PubMed ID: 27098371
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M, Salvaneschi E, Bontempi L, Petese A, Manzo A, Rossi D, Salmona M, Collina S, Bigini P, Curti D.
    Neurobiol Dis; 2014 Feb 01; 62():218-32. PubMed ID: 24141020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.